ArticleInternational journal of biomedical imaging2026
Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images.
Article in International journal of biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images.International journal of biomedical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The analysis of histopathological characteristics from biopsy whole slide images (WSI) is a standard procedure in current diagnostic workflows. For instance, malignancies such as melanoma often require the execution of biopsy to be accurately identified. However, diagnosis can be difficult because of variability in clinical scenarios and in microscopic pictures, as well as the lack of biomarkers availability. In this context, the extraction of shape, texture, and intensity-based features from medical images has proven to be a very promising strategy to uncover latent patterns that may be helpful for diagnosis and prediction of several pathologies. Methods: This study proposes radiomics as a powerful tool for extracting nuclei features and enabling nuclei classification of PUMa dataset melanoma WSIs. More specifically, it evaluates the extraction of radiomics features through PyRadiomics, in comparison with the pathomics tool, namely HistomicsTK, in terms of classification performance. To systematically compare these approaches, three supervised classifiers were trained and tested using the same training/testing splits and usual classification metrics: one on radiomics features, one on histomic features, and one on the merged feature set. Results: The results illustrate an improved performance of the radiomics model compared with both the histomic model and the hybrid radiomics and histomics model, suggesting that radiomics can extract valuable phenotypic information from histological images. Conclusions: Radiomics-based feature extraction, as implemented in PyRadiomics, may be a valid and robust alternative to histomics/pathomics descriptors implemented in HistomicsTK in computational pathology pipelines for melanoma analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.